• Home
• About Lipoxen
• Our Technologies
• Pipeline
• Partnering
• Corporate Governance
• Investor Centre
• News
  • FAQ
  • Contact us
  • Careers

Lipoxen PLC Presenting at Sachs Associates

22 April 2008

Lipoxen PLC Presenting at Sachs Associates, European Life Science CEO Forum Investing and Partnering, Zurich, 22 – 23 April

London, UK, 22 April 2008 – Lipoxen PLC (AIM:LPX) a bio-pharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and oncology drugs, is pleased to announce that M. Scott Maguire, Chief Executive Officer, will be presenting at the Sachs Associates, European Life Science CEO Forum for Investing & Partnering in Biotech, Medtech, Speciality Pharma & Emerging Markets at the Swissôtel, Zurich 22 – 23 April. Mr. Maguire will deliver his presentation on 22 April, 2008 at 11am.

The presentation and further company information will be available at www.lipoxen.com